Invention Grant
- Patent Title: Glycated CD59 peptides, their preparation, and uses thereof
-
Application No.: US17516508Application Date: 2021-11-01
-
Publication No.: US11891448B2Publication Date: 2024-02-06
- Inventor: Jose A. Halperin , Michael Chorev
- Applicant: President and Fellows of Harvard College
- Applicant Address: US MA Cambridge
- Assignee: President and Fellows of Harvard College
- Current Assignee: President and Fellows of Harvard College
- Current Assignee Address: US MA Cambridge
- Agency: Clark & Elbing LLP
- The original application number of the division: US14724911 2015.05.29
- Main IPC: C07K16/28
- IPC: C07K16/28 ; G01N33/68 ; C07K14/705
Abstract:
The present invention provides glycated Amadori products of the CD59 peptide and fragments thereof to be used as tools and among methods for the diagnosis and prognosis of pre-diabetes and diabetes. Certain aspects of the invention include glycated Amadori products of CD59 and fragments thereof to be used for the generation of antibodies and antibody fragments. Still other aspects of the invention include methodologies for the preparation of glycated Amadori products of CD59, fragments thereof, the inventive antibodies, and antibody fragments.
Public/Granted literature
- US20220162333A1 GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF Public/Granted day:2022-05-26
Information query
